Evidence map›Paper›PMID 32922624›Full record

ArticleThe World Allergy Organization journal2020

Standardization of a colorimetric technique for determination of enzymatic activity of diamine oxidase (DAO) and its application in patients with clinical diagnosis of histamine intolerance.

Camila Beltrán-Ortiz, Teresa Peralta, Verónica Ramos, Magdalena Durán, Carolina Behrens, Daniella Maureira, Maria A Guzmán, Carla Bastias, Pablo Ferrer

Open access · goldAbstract read
In one paragraph

Article in The World Allergy Organization journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Camila Beltrán-OrtizSection of Immunology, HIV and Allergy, Department of Medicine, Clinical Hospital University of Chile, Chile.
Teresa PeraltaSection of Immunology, HIV and Allergy, Department of Medicine, Clinical Hospital University of Chile, Chile.
Verónica RamosSection of Immunology, HIV and Allergy, Department of Medicine, Clinical Hospital University of Chile, Chile.
Magdalena DuránSection of Immunology, HIV and Allergy, Department of Medicine, Clinical Hospital University of Chile, Chile.
Carolina BehrensSection of Immunology, HIV and Allergy, Department of Medicine, Clinical Hospital University of Chile, Chile.
Daniella MaureiraSection of Immunology, HIV and Allergy, Department of Medicine, Clinical Hospital University of Chile, Chile.
Maria A GuzmánSection of Immunology, HIV and Allergy, Department of Medicine, Clinical Hospital University of Chile, Chile.
Carla BastiasSection of Immunology, HIV and Allergy, Department of Medicine, Clinical Hospital University of Chile, Chile.
Pablo FerrerSection of Immunology, HIV and Allergy, Department of Medicine, Clinical Hospital University of Chile, Chile.
Hospital Clínico de la Universidad de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiamine Oxidase (DAO) has an essential role for degradation of exogenous histamine in the intestine; thus, histamine intolerance (HI) mainly has been correlated to a low concentration and/or activity of this enzyme. The objective of the study was to standardize a colorimetric technique to measure the enzymatic activity (function) of hDAO to then apply it to a series of 22 patients with a clinical diagnosis of HI.

methodsFor the standardization variables such as volume and type of sample, incubation time, wavelength of maximum absorption, types of substrates, and concentration of oxidized ascorbate were evaluated. Then the activity and concentration of DAO was determined in 22 patients diagnosed with HI and 22 healthy subjects.

resultsThe mean of serum DAO concentration in the 22 patients was of 9.268 ± 1.124 U/mL. The mean of serum DAO concentration in the 22 controls was of 20.710 ± 2.509 U/mL, being significantly higher (P value 0.0002) the mean of the samples. The mean of serum DAO activity of the patients was of 1.143 ± 0.085 U/L and the controls was 1.533 ± 0.119 U/L, significantly greater than the patients (P value 0.011). In addition, the sensitivity of both techniques was 0.63. In the measuring of DAO concentration the specificity was 0.9, constituting a good diagnostic test, especially to rule out the true negatives. The determination of DAO activity had a specificity of 0.68.

conclusionsAlthough we used a small number of patients and controls and the absorbance values were lower than expected, statistically significant differences were found in the levels of concentration and DAO activity between the patients with histamine intolerance and the controls. Therefore, the measuring of DAO concentration and DAO activity is a good diagnostic strategy for study suspect cases of HI. The simultaneous use of both assays allows to reduce positive and negative false results, for example, patients with normal DAO levels that could present a dysfunction in the activity of this enzyme.

Indexed as

ActivityASOD, Ascorbate OxidaseDAODAO, Diamine OxidaseDiamine oxidaseELISA, Enzyme-Linked Immuno Sorbent AssayhDAO, Human Diamine OxidaseHI, Histamine IntoleranceHistamineHistamine intoleranceROC, Receiver Operating CharacteristicTMB, Tetramethylbenzidine

Identifiers

PMID32922624
PMCPMC7475190
OpenAlexW3081811771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.